Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

In 2005, The Ultimate Fighter season 1 helped save the UFC and launched careers that went in wildly different directions. Some fighters became champions, others found success after the cage, and a few ...

Did you know that the 34th season of The Ultimate Fighter (TUF), coached by UFC Hall of Famers Daniel Cormier and Michael Bisping, is currently airing on Paramount+ every Tuesday? Well, if not, I got ...

WASHINGTON – Michael Bisping has quite the history with The Ultimate Fighter. Not only did Bisping enter the UFC by winning season three of The Ultimate Fighter, but the former UFC champion also ...

The Ultimate Fighter is back. Season 34 of The Ultimate Fighter officially premieres June 14 on Paramount+, immediately following UFC Freedom 250. The second episode airs Tuesday, June 16, just two ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Newegg’s Memorial Day Sale is in full swing, and there are some cracking offers on gaming laptops that are well worth checking out. This ASUS TUG Gaming A16 laptop is now $250 off, and coming in at $1 ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an unusually ambitious goal: building AI systems capable of improving themselves ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...